Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
112 studies found for:    cancer | butyrate
Show Display Options
Rank Status Study
21 Completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: suramin;   Drug: therapeutic hydrocortisone;   Procedure: orchiectomy
22 Active, not recruiting
Has Results
Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
Condition: Prostate Cancer
Interventions: Drug: ketoconazole;   Drug: lenalidomide;   Drug: therapeutic hydrocortisone
23 Active, not recruiting Ketoconazole and Dexamethasone in Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Ketoconazole, hydrocortisone;   Drug: Ketoconazole, dexamethasone
24 Recruiting 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: 177Lu-J591;   Drug: Ketoconazole;   Drug: Hydrocortisone;   Drug: 111In-J591
25 Completed
Has Results
Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer
Condition: Prostate Cancer
Intervention: Drug: Ketoconazole, Hydrocortisone and Dutasteride
26 Completed Trilostane for Androgen-Independent Prostate Cancer
Conditions: Prostate Cancer;   Prostate Adenocarcinoma
Interventions: Drug: Trilostane;   Drug: Hydrocortisone
27 Recruiting Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients
Conditions: Colorectal Cancer;   Head and Neck Cancer
Interventions: Drug: Doxycycline;   Drug: Hydrocortisone 1% cream;   Other: Sunscreen;   Other: Moisturizer;   Drug: Clindamycin;   Drug: Medrol-dose pack (Steroid)
28 Recruiting Hydrocortisone vs. Pasireotide in Preventing Pancreatic Surgery Complications
Conditions: Pancreatic Fistula;   Pancreatic Neoplasms
Interventions: Drug: Hydrocortisone;   Drug: Pasireotide
29 Terminated Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel + Estramustine + Hydrocortisone;   Drug: Docetaxel + Prednisone
30 Completed Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: Bicalutamide;   Drug: Doxorubicin hydrochloride;   Drug: Estramustine Phosphate Sodium;   Drug: Flutamide;   Drug: Ketoconazole;   Drug: Nilutamide;   Drug: Therapeutic Hydrocortisone;   Drug: Vinblastine;   Procedure: Conventional Surgery
31 Terminated Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer
Conditions: Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage III Prostate Cancer;   Stage IV Prostate Cancer
Interventions: Dietary Supplement: Calcitriol;   Drug: Ketoconazole;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Therapeutic Hydrocortisone
32 Active, not recruiting Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Conditions: Dermatologic Complications;   Malignant Neoplasm
Interventions: Drug: spironolactone;   Other: placebo;   Other: questionnaire administration;   Drug: sunscreen;   Procedure: management of therapy complications;   Drug: doxycycline;   Drug: therapeutic hydrocortisone
33 Completed
Has Results
Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Condition: Rash
Interventions: Drug: Minocycline;   Drug: Clindamycin 2% in hydrocortisone 1% lotion;   Drug: Erlotinib;   Drug: Topical clindamycin 2%, triamcinolone acetonide 0.1% soln
34 Completed
Has Results
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT
Condition: Central Nervous System Tumor, Pediatric
Interventions: Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy;   Drug: Dactinomycin
35 Not yet recruiting Salivary Free Cortisol Response to Cosyntropin Stimulation Test in Mitotane Treated Patients
Conditions: Adrenal Insufficiency;   Adrenal Cancer
Intervention: Diagnostic Test: Cosyntropin stimulation test
36 Completed
Has Results
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
Conditions: Metastatic Colorectal Cancer;   Skin Rash;   Skin Toxicities;   Colon Cancer;   Colorectal Cancer
Interventions: Biological: Panitumumab;   Drug: Irinotecan;   Drug: FOLFIRI;   Drug: Pre-emptive Skin Treatment;   Drug: Reactive Skin Treatment
37 Completed 506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Lymphoblastic Lymphoma;   T-cell Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: nelarabine;   Drug: methotrexate;   Drug: cytarabine;   Drug: therapeutic hydrocortisone
38 Terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Interventions: Drug: suramin;   Drug: therapeutic hydrocortisone
39 Unknown  Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Conditions: Pituitary Neoplasms;   Craniopharyngiomas
Interventions: Drug: Hydrocortisone;   Drug: Prednisone
40 Active, not recruiting Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
Condition: Acute Myeloid Leukemia
Interventions: Drug: Crenolanib;   Drug: Sorafenib;   Drug: methotrexate, hydrocortisone and cytarabine with leucovorin

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.